Post‐Acute Sequelae Patients with Severe COVID‐19 History Show a Prolonged Inflammatory, Vascular Injury Pattern

Read full text Summarise with VIRAT
Authors: Louisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, Nora Drick, Andrea Sauer, Lennart Boblitz, Kerstin Beushausen, Jana Keil, Anna‐Lena Ullrich, Julius J. Schmidt, Marius M. Hoeper, Tobias Welte
+2 more Jenny F. Kühne, Christine Susanne Falk
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

SARS‐CoV‐2 infection can lead to persistent symptoms (i.e., long/post‐COVID), especially in unvaccinated individuals. Little is known about the sustained impact of acute severe COVID‐19 on immune signatures and long/post‐COVID symptoms, often associated with cardiovascular events and pulmonary impairment. The longitudinal cohort (LC) was obtained from N = 46 patients with previous severe COVID‐19 and prior to SARS‐CoV‐2 vaccination, collected over 5 visits up to 12 months after discharge ( n = 139). Long/post‐COVID status was assessed by lung function and fatigue scores. Blood was analysed regarding immune cell profiles, SARS‐CoV‐2 antibodies, and autoantigens. LC patients were compared with 39 acute severe COVID‐19 ICU patients and 28 unexposed pre‐pandemic donors (UE) and correlated with clinical parameters. LC patients exhibited long‐term decreased CD4 + /CD8 + T cell ratio, differentiation from naïve to TEMRA, CD57 + CCR7 − memory, and HLA‐DR + CD38 + activated CD4 + and CD8 + T cells. LC plasma profiles displayed elevated levels of markers for chronic inflammation and endothelial injury. Chronic inflammatory chemokines and cardiovascular markers remained high. These markers and autoantibodies against centromere structures negatively correlated with lung function. At 1‐year post‐discharge, LC patients with a COVID‐19 ICU history displayed sustained significant changes in their immune profile at cellular and inflammatory levels, revealing signatures of persistent inflammation and endothelial injury.

Fields of Study & Subjects

Long-Term Effects of COVID-19 COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research

Publication details

Journal / source
European Journal of Immunology
Volume
56
Issue
4
Pages
e70169–e70169
Publication date
29 March 2026
Language
EN